AU Patent

AU5729098A — Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes

Assigned to Zymogenetics Inc · Expires 1998-07-17 · 28y expired

What this patent protects

Patent listed against Mifeprex.

Drugs covered by this patent

Patent Metadata

Patent number
AU5729098A
Jurisdiction
AU
Classification
—
Expires
1998-07-17
Drug substance claim
No
Drug product claim
No
Assignee
Zymogenetics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.